Skip to content

BeZuHG - Being treated at home for mental reconvalescence (Behandelt zu Hause Gesund Werden)

Effectiveness of home treatment supplemented by clinical elements versus regular in-patient care in children and adolescents with psychiatric disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN02672532
Enrollment
292
Registered
2014-08-11
Start date
2011-10-01
Completion date
Unknown
Last updated
2021-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental disorders in children and adolescents requiring inpatient care Mental and Behavioural Disorders

Interventions

Control: 146 adolescents will receive usual inpatient care Intervention: 96 patients will be discharged early with intensive community support in combination with clinical elements pro

Sponsors

University of Ulm
Lead Sponsor
ZfP-Suedwuerttemberg
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Part one and two: Hospital inpatient stay for more than 72 hours All parts: 1. Age: Between 5 and 18 years 2. Psychiatric diagnosis (DSM IV/ICD10) 3. Child/adolescent lives in a family setting 4. Youth and family live within the catchment area in a reasonable distance (max 1 hour travel) to allow home treatment on a regular basis 5. IQ> 70

Exclusion criteria

Exclusion criteria: 1. Youth lives in a youth welfare setting 2. Absence of consent of parents or child/youth 3. Limited language skills in families whose first language is not German

Design outcomes

Primary

MeasureTime frame
Generally there are 3 timepoints for both primary and secondary outcomes at which data is collected: T1 - within 14 days after inclusion into the study T2 - after completion of treatment (control group: discharge from inpatient stay, intervention group: completion of BeZuHG treatment) T3 - 6 month follow up 1. Duration of psychiatric inpatient stay during treatment and a 6 month follow-up period (i.e. T2 and T3) 2. CGAS (Childrens global assessment Scale) This is a paediatric measure of general functioning (T1, T2 and T3)

Secondary

MeasureTime frame
1. SDQ (strengths and difficulties questionnaire, childrens and parents version) This is a broad measure of psychopathology in children and adolescents (T1, T2 and T3) 2. HoNOSCA (Health of the Nation Outcome Scales for Children and Adolescents). It is a clinician rated tool, that assesses symptom severity and function across a range of psychosocial domains (T1, T2 and T3) 3. ZUF 8 (Fragebogen zur Patientenzufriedenheit - Questionnaire for service satisfaction) (T2 and T3) 4. Qualitative semi-structured interview regarding patient satisfaction (T3) 5. Cost: Information on the use of inpatient hospital services, community services, out-patient services, social services, school support will be collected over the study period (T2 and T3) 6. Clinical diagnosis: K-SADS-PL (schedule for affective disorders and Schizophrenia for school-age children, Present and Lifetime Version) (T1) 7. Columbia Impairment Scale (T1, T2 and T3)

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 5, 2026